Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $239.36 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $118.94 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $108.64 | 1 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $11.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $108.64 | 1 | Janssen Biotech, Inc. ($108.64) |
| 2019 | $118.94 | 1 | GlaxoSmithKline, LLC. ($118.94) |
| 2017 | $11.78 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($11.78) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $108.64 | General |
| Category: Immunology | ||||||
| 10/10/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $118.94 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,793 | 10,449 | $760,744 | $222,628 |
| 2022 | 22 | 2,049 | 11,918 | $878,812 | $257,411 |
| 2021 | 20 | 1,838 | 7,870 | $538,087 | $179,061 |
| 2020 | 5 | 82 | 84 | $14,492 | $4,089 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 78 | 7,560 | $396,371 | $137,238 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 501 | $165,860 | $45,377 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 268 | $60,944 | $16,347 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 307 | 578 | $11,560 | $4,855 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,090 | $2,294 | 22.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 120 | 260 | $8,320 | $2,083 | 25.0% |
| 82565 | Blood creatinine level | Office | 2023 | 227 | 402 | $8,040 | $2,018 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $7,448 | $1,987 | 26.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 53 | 53 | $13,356 | $1,596 | 11.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $3,060 | $1,516 | 49.5% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 34 | 34 | $5,238 | $1,378 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 79 | 133 | $10,374 | $1,336 | 12.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 27 | 27 | $9,396 | $1,174 | 12.5% |
| 82310 | Calcium level, total | Office | 2023 | 120 | 173 | $3,460 | $875.38 | 25.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 29 | 145 | $41,325 | $825.30 | 2.0% |
| 82040 | Albumin (protein) level | Office | 2023 | 107 | 154 | $2,926 | $746.90 | 25.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,800 | $629.40 | 35.0% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 56 | 84 | $1,176 | $351.12 | 29.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 95 | 8,520 | $443,558 | $144,765 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 338 | 693 | $213,444 | $64,857 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 218 | $45,780 | $14,976 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $29,140 | $7,732 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 39 | $15,990 | $5,622 | 35.2% |
| 80076 | Liver function blood test panel | Office | 2022 | 133 | 310 | $9,920 | $2,504 | 25.2% |
| 82565 | Blood creatinine level | Office | 2022 | 261 | 468 | $9,360 | $2,367 | 25.3% |
About Dr. Jennifer Winslow, DO
Dr. Jennifer Winslow, DO is a Rheumatology healthcare provider based in Palmer, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2014. The National Provider Identifier (NPI) number assigned to this provider is 1477972701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Winslow, DO has received a total of $239.36 in payments from pharmaceutical and medical device companies, with $108.64 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($239.36).
As a Medicare-enrolled provider, Winslow has provided services to 5,762 Medicare beneficiaries, totaling 30,321 services with total Medicare billing of $663,189. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Palmer, MA
- Active Since 04/15/2014
- Last Updated 09/17/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1477972701
Products in Payments
- BENLYSTA (Biological) $118.94
- TREMFYA (Drug) $108.64
- LifeVest (Device) $11.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.